Phytosterol CHD Health Claim Expanded Interim Use Permitted By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA will allow the use of a phytosterol heart health claim on a broader range of foods, beverages and dietary supplements while it completes a final rule on the issue, according to a Feb. 14 open letter posted on the agency's Web site
You may also be interested in...
Limit On Phytosterol CHD Health Claim Would Disrupt Industry – Cargill
Dietary supplement industry stakeholders "urgently" ask FDA to continue allowing coronary heart disease reduction health claims for supplements with nonesterified phytosterols, or risk "irreparable injury" to some firms.
Limit On Phytosterol CHD Health Claim Would Disrupt Industry – Cargill
Dietary supplement industry stakeholders "urgently" ask FDA to continue allowing coronary heart disease reduction health claims for supplements with nonesterified phytosterols, or risk "irreparable injury" to some firms.
Limit On Phytosterol CHD Health Claim Would Disrupt Industry – Cargill
Dietary supplement industry stakeholders "urgently" ask FDA to continue allowing coronary heart disease reduction health claims for supplements with nonesterified phytosterols, or risk "irreparable injury" to some firms.